Machine learning modeling of family wide enzyme-substrate specificity screens

Biocatalysis is a promising approach to sustainably synthesize pharmaceuticals, complex natural products, and commodity chemicals at scale. However, the adoption of biocatalysis is limited by our ability to select enzymes that will catalyze their natural chemical transformation on non-natural substr...

ver descrição completa

Detalhes bibliográficos
Main Authors: Goldman, Samuel, Das, Ria, Yang, Kevin K, Coley, Connor W
Formato: Artigo
Idioma:English
Publicado em: Public Library of Science (PLoS) 2022
Acesso em linha:https://hdl.handle.net/1721.1/141379
_version_ 1826201596187377664
author Goldman, Samuel
Das, Ria
Yang, Kevin K
Coley, Connor W
author_facet Goldman, Samuel
Das, Ria
Yang, Kevin K
Coley, Connor W
author_sort Goldman, Samuel
collection MIT
description Biocatalysis is a promising approach to sustainably synthesize pharmaceuticals, complex natural products, and commodity chemicals at scale. However, the adoption of biocatalysis is limited by our ability to select enzymes that will catalyze their natural chemical transformation on non-natural substrates. While machine learning and <jats:italic>in silico</jats:italic> directed evolution are well-posed for this predictive modeling challenge, efforts to date have primarily aimed to increase activity against a single known substrate, rather than to identify enzymes capable of acting on new substrates of interest. To address this need, we curate 6 different high-quality enzyme family screens from the literature that each measure multiple enzymes against multiple substrates. We compare machine learning-based compound-protein interaction (CPI) modeling approaches from the literature used for predicting drug-target interactions. Surprisingly, comparing these interaction-based models against collections of independent (single task) enzyme-only or substrate-only models reveals that current CPI approaches are incapable of learning interactions between compounds and proteins in the current family level data regime. We further validate this observation by demonstrating that our no-interaction baseline can outperform CPI-based models from the literature used to guide the discovery of kinase inhibitors. Given the high performance of non-interaction based models, we introduce a new structure-based strategy for pooling residue representations across a protein sequence. Altogether, this work motivates a principled path forward in order to build and evaluate meaningful predictive models for biocatalysis and other drug discovery applications.
first_indexed 2024-09-23T11:54:12Z
format Article
id mit-1721.1/141379
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T11:54:12Z
publishDate 2022
publisher Public Library of Science (PLoS)
record_format dspace
spelling mit-1721.1/1413792022-03-29T03:24:58Z Machine learning modeling of family wide enzyme-substrate specificity screens Goldman, Samuel Das, Ria Yang, Kevin K Coley, Connor W Biocatalysis is a promising approach to sustainably synthesize pharmaceuticals, complex natural products, and commodity chemicals at scale. However, the adoption of biocatalysis is limited by our ability to select enzymes that will catalyze their natural chemical transformation on non-natural substrates. While machine learning and <jats:italic>in silico</jats:italic> directed evolution are well-posed for this predictive modeling challenge, efforts to date have primarily aimed to increase activity against a single known substrate, rather than to identify enzymes capable of acting on new substrates of interest. To address this need, we curate 6 different high-quality enzyme family screens from the literature that each measure multiple enzymes against multiple substrates. We compare machine learning-based compound-protein interaction (CPI) modeling approaches from the literature used for predicting drug-target interactions. Surprisingly, comparing these interaction-based models against collections of independent (single task) enzyme-only or substrate-only models reveals that current CPI approaches are incapable of learning interactions between compounds and proteins in the current family level data regime. We further validate this observation by demonstrating that our no-interaction baseline can outperform CPI-based models from the literature used to guide the discovery of kinase inhibitors. Given the high performance of non-interaction based models, we introduce a new structure-based strategy for pooling residue representations across a protein sequence. Altogether, this work motivates a principled path forward in order to build and evaluate meaningful predictive models for biocatalysis and other drug discovery applications. 2022-03-28T19:31:43Z 2022-03-28T19:31:43Z 2022-02 2022-03-28T18:32:41Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/141379 Goldman, Samuel, Das, Ria, Yang, Kevin K and Coley, Connor W. 2022. "Machine learning modeling of family wide enzyme-substrate specificity screens." PLOS Computational Biology, 18 (2). en 10.1371/journal.pcbi.1009853 PLOS Computational Biology Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Public Library of Science (PLoS) 625865
spellingShingle Goldman, Samuel
Das, Ria
Yang, Kevin K
Coley, Connor W
Machine learning modeling of family wide enzyme-substrate specificity screens
title Machine learning modeling of family wide enzyme-substrate specificity screens
title_full Machine learning modeling of family wide enzyme-substrate specificity screens
title_fullStr Machine learning modeling of family wide enzyme-substrate specificity screens
title_full_unstemmed Machine learning modeling of family wide enzyme-substrate specificity screens
title_short Machine learning modeling of family wide enzyme-substrate specificity screens
title_sort machine learning modeling of family wide enzyme substrate specificity screens
url https://hdl.handle.net/1721.1/141379
work_keys_str_mv AT goldmansamuel machinelearningmodelingoffamilywideenzymesubstratespecificityscreens
AT dasria machinelearningmodelingoffamilywideenzymesubstratespecificityscreens
AT yangkevink machinelearningmodelingoffamilywideenzymesubstratespecificityscreens
AT coleyconnorw machinelearningmodelingoffamilywideenzymesubstratespecificityscreens